Harnessing aptamers against COVID-19: A therapeutic strategy
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference70 articles.
1. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift;Cameroni;Nature,2022
2. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis;Di Toro;Leukemia,2020
3. SARS-CoV-2 evolution during treatment of chronic infection;Kemp;Nature,2021
4. Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2;Bozgeyik;Meta Gene,2021
5. Recent progress in aptamer discoveries and modifications for therapeutic applications;Ni;ACS Appl Mater Interfaces,2021
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An ultrasensitive and specific fluorescence split-aptasensor for VEGF165 detection based on nicking enzyme-assisted 3D DNA walker coupling with CRISPR-Cas12a;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2025-01
2. Aptamer-decorated nanocarriers for viral adsorption: A special look at COVID-19;Molecular Therapy - Nucleic Acids;2024-09
3. Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections;Journal of Inflammation Research;2024-07
4. Therapeutic Applications of Aptamers;International Journal of Molecular Sciences;2024-06-19
5. Improving synthesis and binding affinities of nucleic acid aptamers and their therapeutics and diagnostic applications;Biophysical Chemistry;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3